Founder of Aciex and President since inception. Responsible for strategic direction of company, fund raising, investor relations and overseeing resources for clinical development projects, intellectual property, product partnering activities, and finance and administration. More than 20 years experience raising money and managing companies. Aciex is the fourth start-up. MBA from Kellogg School of Management. BA from University of Binghamton.

25 years pharma experience at GSK & Novartis. Proven track record leading successful research projects. Areas of expertise include respiratory diseases (asthma, COPD, cystic fibrosis, allergy, etc.). Significant contribution to development of brands such as Advair, Serevent, Flovent, Flonase, Xolair, etc. BS in Physiology/Medical Biology from University of St. Andrews and PhD in Pharmacology from University of London